GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » Gross Margin %

STEK (Stemtech) Gross Margin % : 63.08% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stemtech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Stemtech's Gross Profit for the three months ended in Sep. 2024 was $0.65 Mil. Stemtech's Revenue for the three months ended in Sep. 2024 was $1.03 Mil. Therefore, Stemtech's Gross Margin % for the quarter that ended in Sep. 2024 was 63.08%.


The historical rank and industry rank for Stemtech's Gross Margin % or its related term are showing as below:

STEK' s Gross Margin % Range Over the Past 10 Years
Min: 74.47   Med: 77.98   Max: 83.67
Current: 74.94


During the past 4 years, the highest Gross Margin % of Stemtech was 83.67%. The lowest was 74.47%. And the median was 77.98%.

STEK's Gross Margin % is ranked better than
88.44% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs STEK: 74.94

Stemtech had a gross margin of 63.08% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Stemtech was 0.00% per year.


Stemtech Gross Margin % Historical Data

The historical data trend for Stemtech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech Gross Margin % Chart

Stemtech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Margin %
83.67 76.32 74.47 79.64

Stemtech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.58 83.85 74.98 74.96 63.08

Competitive Comparison of Stemtech's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Stemtech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemtech's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemtech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Stemtech's Gross Margin % falls into.



Stemtech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Stemtech's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3.9 / 4.922
=(Revenue - Cost of Goods Sold) / Revenue
=(4.922 - 1.002) / 4.922
=79.64 %

Stemtech's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=0.7 / 1.032
=(Revenue - Cost of Goods Sold) / Revenue
=(1.032 - 0.381) / 1.032
=63.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Stemtech  (OTCPK:STEK) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Stemtech had a gross margin of 63.08% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Stemtech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Stemtech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemtech Business Description

Traded in Other Exchanges
N/A
Address
4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.
Executives
Charles Stuart Arnold director 520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc. 10 percent owner 419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green director 300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer director 10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan director 13005 CORONOADO LANE, NORTH MIAMI FL 33181